Reorganization of Arenavirus Genome for Development of Novel Arenavirus Live-Attenuated Vaccines (LAV)

Disclosed are compositions and methods related to recombinant arenaviruses and their use in vaccines for the treatment or prevention of an arenavirus infection.

URV Reference Number: 6-15148
Patent Information:
Title Country Patent No. Issued Date
Methods and Compositions Related to Reorganization of Arenavirus Genome for Development of Novel Arenavirus Live-Attenuated Vaccines (LAV) United States 9,943,585 4/17/2018
Category(s):
Vaccines
For Information, Contact:
Matan Rapoport
Licensing Associate
University of Rochester
585.276.6600
matan.rapoport@rochester.edu
Inventors:
Juan Carlos De La Torre
Luis Martinez-Sobrido
Masaharu Iwasaki
Beatrice Cubitt
Keywords: